Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Yingjie JIA"'
Autor:
Yajie Liu, Pengxing He, Xubin Ma, Yingqi Tian, Yu Zhang, Yang Wang, Yingjie Jia, Hongmin Liu, Ying Liu, Yichao Xu
Publikováno v:
Genes and Diseases, Vol 12, Iss 1, Pp 101265- (2025)
Externí odkaz:
https://doaj.org/article/6dd271151c9c475795fe99bd6a6e64f8
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundImmunotherapy offers new hope for improved survival in patients with advanced gastric cancer. Although large randomized controlled trials (RCTs) have been conducted to explore the efficacy and safety of first-line immunotherapy plus chemoth
Externí odkaz:
https://doaj.org/article/15299449cd5841758ba4cec66d408272
Publikováno v:
Frontiers in Molecular Biosciences, Vol 11 (2024)
Background and ObjectiveEnhancing therapy choices for varying stages of esophageal cancer and improving patient survival depend on timely and precise diagnosis. Blood metabolites may play a role in either causing or preventing esophageal cancer, but
Externí odkaz:
https://doaj.org/article/971140e07646457f81f59dc2caaed657
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Objective To investigate whether a causal relationship exists between the estimated glomerular filtration rate (EGFR) and the occurrence of prostate cancer in East Asian and European populations and to determine if genetic factors influence
Externí odkaz:
https://doaj.org/article/dd78bceec4bb45db9246573a07c5d7f6
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-13 (2023)
Abstract Various new treatments are emerging constantly in anti-tumor therapies, including chemotherapy, immunotherapy, and targeted therapy. However, the efficacy is still not satisfactory. Astragalus polysaccharide is an important bioactive compone
Externí odkaz:
https://doaj.org/article/615f4c5d937449528dcb4065d5ab239c
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Pancreatic cancer is one of the deadliest malignant tumors, which is a serious threat to human health and life, and it is expected that pancreatic cancer may be the second leading cause of cancer death in developed countries by 2030. Claudin18.2 is a
Externí odkaz:
https://doaj.org/article/4e138550f2e949f8bec191d8251c4ead
Publikováno v:
Translational Oncology, Vol 41, Iss , Pp 101893- (2024)
Triple-negative breast cancer (TNBC) is a subtype of breast cancer with poor prognosis. The number of cases increased by 2.26 million in 2020, making it the most commonly diagnosed cancer type in the world. TNBCs lack hormone receptor (HR) and human
Externí odkaz:
https://doaj.org/article/0305601a4a31491498746d3ceb0c6951
Autor:
Longhui Li, Yangyueying Liang, Minghui Yu, Lu Zhao, Qingyun Mei, Yongchao Yu, Na Wang, Dou Zhang, Ziwei Wang, Yingjie Jia, Fanming Kong
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11097-11106 (2023)
Abstract Background As one of the most aggressive neuroendocrine tumors, small cell lung cancer (SCLC) has the most disappointing prognosis of all lung cancers. Although SCLC responds well to initial chemotherapy, the majority of patients experience
Externí odkaz:
https://doaj.org/article/0c41a4f67aa44c6889bfc5ddbc3f1c2b
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-19 (2023)
Abstract Regucalcin (RGN) is a potent inhibitory protein of calcium signaling and expresses in various tissues. However, the role of RGN in the tumor immunological microenvironment in lung squamous cell carcinoma (LUSC) remains unclear. This study id
Externí odkaz:
https://doaj.org/article/9eb26771d8fd4f5db5eabc2d603190c4
Autor:
Dou Zhang, Fanming Kong, Fangfang Gao, Longhui Li, Yangyueying Liang, Minghui Yu, Lu Zhao, Na Wang, Yingjie Jia
Publikováno v:
Heliyon, Vol 10, Iss 1, Pp e22913- (2024)
Objective: Exploring the clinical efficacy of camrelizumab in combination with first-line chemotherapy in patients with extensive-stage small-cell lung cancer (ES-SCLC). Methods: The clinical data of 35 patients with ES-SCLC who received camrelizumab
Externí odkaz:
https://doaj.org/article/d32b4aeb4c904c43a165de5fcc218785